Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;94(10):5033-5037.
doi: 10.1002/jmv.27908. Epub 2022 Jun 10.

Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sublineage

Gannon C K Mak  1 , Stephen S Y Lau  1 , Kitty K Y Wong  1 , Chi-Shan Lau  1 , Ken H L Ng  1 , Edman T K Lam  1 , Rickjason C W Chan  1
Affiliations

Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sublineage

Gannon C K Mak et al. J Med Virol. 2022 Oct.

Abstract

The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) Omicron was classified as a variant of concern in November 2021. The sublineage BA.2 spreads rapidly worldwide. Currently, there is a lack of data for the parallel comparison of Rapid Antigen Test (RAT) Kits to detect SARS-CoV-2 Omicron BA.2. We evaluated the analytical sensitivity of 12 RAT kits to detect Omicron BA.2 in the present study. Analytical sensitivity was determined by means of the limit of detection (LOD). We prepared a dilution set using a respiratory specimen collected from a COVID-19 patient infected by Omicron BA.2. The reverse transcription-polymerase chain reaction was used as a reference method. The LOD results showed that all 12 RAT kits had comparable analytical sensitivity to detect Omicron BA.2. The RAT kits selected in the current study may be used for the first-line screening of the rapid spreading Omicron BA.2.

Keywords: B.1.1.529; BA.2; COVID-19; Omicron; Rapid Antigen Test; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. WHO . Classification of Omicron (B.1.1.529): SARS‐CoV‐2 variant of concern. November 26, 2021. Accessed March 21, 2022. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1....
    1. WHO . Enhancing response to Omicron SARS‐CoV‐2 variant. January 21, 2022. Accessed March 21, 2022. https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-...
    1. WHO . Weekly epidemiological update on COVID‐19–15 March 2022. Edition 83. March 15, 2022. Accessed March 21, 2022. https://www.who.int/publications/m/item/weekly-epidemiological-update-on...
    1. Tsang AK, Cheng PK, Mak GC, et al. Unusual high number of spike protein mutations for the SARS‐CoV‐2 strains detected in Hong Kong. J Clin Virol. 2022;148:105081. 10.1016/j.jcv.2022.105081 - DOI - PMC - PubMed
    1. Cheng VC, Ip JD, Chu AW, et al. Rapid spread of SARS‐CoV‐2 Omicron subvariant BA.2 in a single‐source community outbreak. Clin Infect Dis. Published online March 10, 2022. 10.1093/cid/ciac203 - DOI - PMC - PubMed

Supplementary concepts